Literature DB >> 28327344

Direct activation of Ca2+ and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor.

Alexander I Bondarenko1, Olga Panasiuk2, Iryna Okhai2, Fabrizio Montecucco3, Karim J Brandt4, Francois Mach4.   

Abstract

Endocannabinoid anandamide induces endothelium-dependent relaxation commonly attributed to stimulation of the G-protein coupled endothelial anandamide receptor. The study addressed the receptor-independent effect of anandamide on large conductance Ca2+-dependent K+ channels expressed in endothelial cell line EA.hy926. Under resting conditions, 10µM anandamide did not significantly influence the resting membrane potential. In a Ca2+-free solution the cells were depolarized by ~10mV. Further administration of 10µM anandamide hyperpolarized the cells by ~8mV. In voltage-clamp mode, anandamide elicited the outwardly rectifying whole-cell current sensitive to paxilline but insensitive to GDPβS, a G-protein inhibitor. Administration of 70µM Mn2+, an agent used to promote integrin clustering, reversibly stimulated whole-cell current, but failed to further facilitate the anandamide-stimulated current. In an inside-out configuration, anandamide (0.1-30µM) facilitated single BKCa channel activity in a concentration-dependent manner within a physiological Ca2+ range and a wide range of voltages, mainly by reducing mean closed time. The effect is essentially eliminated following chelation of Ca2+ from the cytosolic face and pre-exposure to cholesterol-reducing agent methyl-β-cyclodextrin. O-1918 (3µM), a cannabidiol analog used as a selective antagonist of endothelial anandamide receptor, reduced BKCa channel activity in inside-out patches. These results do not support the existence of endothelial cannabinoid receptor and indicate that anandamide acts as a direct BKCa opener. The action does not require cell integrity or integrins and is caused by direct modification of BKCa channel activity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anandamide; BK(Ca) channels; Endothelial cannabinoid receptor; Integrins

Mesh:

Substances:

Year:  2017        PMID: 28327344      PMCID: PMC6520242          DOI: 10.1016/j.ejphar.2017.03.038

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  65 in total

1.  Membrane potential as a modulator of the free intracellular Ca2+ concentration in agonist-activated endothelial cells.

Authors:  M Kamouchi; G Droogmans; B Nilius
Journal:  Gen Physiol Biophys       Date:  1999-06       Impact factor: 1.512

2.  Functional CB1 cannabinoid receptors in human vascular endothelial cells.

Authors:  J Liu; B Gao; F Mirshahi; A J Sanyal; A D Khanolkar; A Makriyannis; G Kunos
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

3.  Impaired hyperpolarization in regenerated endothelium after balloon catheter injury.

Authors:  R Köhler; S Brakemeier; M Kühn; C Behrens; R Real; C Degenhardt; H D Orzechowski; A R Pries; M Paul; J Hoyer
Journal:  Circ Res       Date:  2001-07-20       Impact factor: 17.367

4.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Authors:  Z Járai; J A Wagner; K Varga; K D Lake; D R Compton; B R Martin; A M Zimmer; T I Bonner; N E Buckley; E Mezey; R K Razdan; A Zimmer; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Acetylcholine-induced membrane potential changes in endothelial cells of rabbit aortic valve.

Authors:  M Ohashi; K Satoh; T Itoh
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

6.  Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells.

Authors:  J V Mombouli; G Schaeffer; S Holzmann; G M Kostner; W F Graier
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

7.  Potassium (BK(Ca)) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats.

Authors:  Christiana Dimitropoulou; Guichun Han; Allison W Miller; Mariela Molero; Leslie C Fuchs; Richard E White; Gerald O Carrier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-03       Impact factor: 4.733

8.  Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.

Authors:  László Offertáler; Fong-Ming Mo; Sándor Bátkai; Jie Liu; Malcolm Begg; Raj K Razdan; Billy R Martin; Richard D Bukoski; George Kunos
Journal:  Mol Pharmacol       Date:  2003-03       Impact factor: 4.436

Review 9.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

10.  Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing store-operated Ca2+ entry dependent on TRPC1.

Authors:  Andreas Bergdahl; Maria F Gomez; Karl Dreja; Shang-Zhong Xu; Mikael Adner; David J Beech; Jonas Broman; Per Hellstrand; Karl Swärd
Journal:  Circ Res       Date:  2003-10-09       Impact factor: 17.367

View more
  3 in total

1.  Combining endocannabinoids with retigabine for enhanced M-channel effect and improved KV7 subtype selectivity.

Authors:  Johan E Larsson; Urban Karlsson; Xiongyu Wu; Sara I Liin
Journal:  J Gen Physiol       Date:  2020-08-03       Impact factor: 4.086

Review 2.  Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol.

Authors:  Changqing Xu; Yumin Zhang; David Gozal; Paul Carney
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-20

3.  Potassium channels as molecular targets of endocannabinoids.

Authors:  Yu-Fung Lin
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.